Genomictree Inc. (228760.KQ)

KRW 23550.0

(3.06%)

Inventory Summary of Genomictree Inc.

  • Genomictree Inc.'s latest annual inventory in 2023 was 496.53 Million KRW , down -21.86% from previous year.
  • Genomictree Inc.'s latest quarterly inventory in 2024 Q2 was 427.27 Million KRW , down -15.84% from previous quarter.
  • Genomictree Inc. reported annual inventory of 635.45 Million KRW in 2022, up 123.07% from previous year.
  • Genomictree Inc. reported annual inventory of 284.86 Million KRW in 2021, down -76.86% from previous year.
  • Genomictree Inc. reported quarterly inventory of 507.71 Million KRW for 2024 Q1, up 2.25% from previous quarter.
  • Genomictree Inc. reported quarterly inventory of 496.53 Million KRW for 2023 Q4, down -18.44% from previous quarter.

Annual Inventory Chart of Genomictree Inc. (2023 - 2016)

Historical Annual Inventory of Genomictree Inc. (2023 - 2016)

Year Inventory Inventory Growth
2023 496.53 Million KRW -21.86%
2022 635.45 Million KRW 123.07%
2021 284.86 Million KRW -76.86%
2020 1.23 Billion KRW 361.98%
2019 266.53 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Inventory Comparison of Genomictree Inc.

Name Inventory Inventory Difference
HLB Co., Ltd. 11.42 Billion KRW 95.653%
iNtRON Biotechnology, Inc. 1.01 Billion KRW 50.892%
BINEX Co., Ltd. 28.26 Billion KRW 98.243%
Bioneer Corporation 41.35 Billion KRW 98.799%
Anterogen.Co.,Ltd. 1.91 Billion KRW 74.01%
MEDIPOST Co., Ltd. 14.51 Billion KRW 96.58%
CrystalGenomics, Inc. 1.55 Billion USD 68.064%
Helixmith Co., Ltd 914.11 Million KRW 45.682%
Chabiotech Co.,Ltd. 34.11 Billion KRW 98.545%
Medy-Tox Inc. 59.61 Billion KRW 99.167%
Peptron, Inc. 172.18 Million KRW -188.367%
Amicogen, Inc. 46.83 Billion KRW 98.94%
Genexine, Inc. 3.8 Billion KRW 86.957%
HLB Therapeutics Co.,Ltd. 5.33 Billion KRW 90.694%
LegoChem Biosciences, Inc. 196.83 Million KRW -152.258%
ALTEOGEN Inc. 1.06 Billion KRW 53.524%
PharmaResearch Co., Ltd. 50.23 Billion KRW 99.012%
SillaJen, Inc. 1.21 Billion KRW 59.053%
JETEMA, Co., Ltd. 12.74 Billion KRW 96.103%
OliX Pharmaceuticals,Inc 468.4 Million KRW -6.004%
MedPacto, Inc. 620.00 KRW -80085613.548%
D&D Pharmatech 3.45 Billion KRW 85.609%
EASY BIO,Inc. 25.93 Billion KRW 98.086%
GI Innovation, Inc. - KRW -Infinity%